These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 9241131)
1. Antioxidants and atherosclerotic heart disease. Diaz MN; Frei B; Vita JA; Keaney JF N Engl J Med; 1997 Aug; 337(6):408-16. PubMed ID: 9241131 [TBL] [Abstract][Full Text] [Related]
2. Vitamin E and cardiovascular disease. Saremi A; Arora R Am J Ther; 2010; 17(3):e56-65. PubMed ID: 19451807 [TBL] [Abstract][Full Text] [Related]
3. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Jialal I; Fuller CJ Can J Cardiol; 1995 Oct; 11 Suppl G():97G-103G. PubMed ID: 7585302 [TBL] [Abstract][Full Text] [Related]
4. [The significance of ixidized low density lipoprotein in atherosclerosis]. Hansen PR Ugeskr Laeger; 1996 May; 158(19):2706-10. PubMed ID: 8744072 [TBL] [Abstract][Full Text] [Related]
5. [Antioxidant vitamins--significance for preventing cardiovascular diseases. Part 1. Oxidized low-density lipoproteins and atherosclerosis; antioxidant dietary supplementation--vitamin E]. Andreeva-Gateva P Vutr Boles; 2000; 32(3):11-8. PubMed ID: 11688317 [TBL] [Abstract][Full Text] [Related]
6. Role of oxidative modifications in atherosclerosis. Stocker R; Keaney JF Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655 [TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies. Napoli C G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066 [TBL] [Abstract][Full Text] [Related]
8. Oxidised low density lipoprotein, antioxidants and coronary atherosclerosis. Gambhir DS; Gambhir JK Indian Heart J; 1997; 49(1):19-22. PubMed ID: 9130420 [No Abstract] [Full Text] [Related]
9. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Aviram M Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334 [TBL] [Abstract][Full Text] [Related]
11. Antioxidants and the prevention of coronary heart disease. Hoffman RM; Garewal HS Arch Intern Med; 1995 Feb; 155(3):241-6. PubMed ID: 7832595 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen is a co-antioxidant that supplements the vitamin E analog trolox in a model system. Abudu N; Miller JJ; Levinson SS Free Radic Res; 2006 Mar; 40(3):321-31. PubMed ID: 16484048 [TBL] [Abstract][Full Text] [Related]
13. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Lopes-Virella MF Eur Heart J; 1993 Dec; 14 Suppl K():118-24. PubMed ID: 8131779 [TBL] [Abstract][Full Text] [Related]
14. Dietary antioxidants and cardioprotection--fact or fallacy? Steinbrecher UP Can J Physiol Pharmacol; 1997 Mar; 75(3):228-33. PubMed ID: 9164706 [TBL] [Abstract][Full Text] [Related]
15. [Lipoproteins, antioxidants, and coronary cardiopathy]. Guimarães AC Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520 [No Abstract] [Full Text] [Related]
17. [Vitamin E and coronary heart disease--why the lack of effect in large clinical trials?]. Andersen JR Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1932-6. PubMed ID: 11488186 [TBL] [Abstract][Full Text] [Related]
18. The antioxidant vitamins: impact on atherosclerosis. Meyers DG; Maloley PA Pharmacotherapy; 1993; 13(6):574-82. PubMed ID: 8302680 [TBL] [Abstract][Full Text] [Related]